Publication Name	World Journal of Hepatology
Manuscript ID	80444
Country	Iran

Received	2022-09-28 00:22
Peer-Review Started	2022-09-28 00:24
To Make the First Decision
Return for Revision	2023-01-04 16:23
Revised	2023-02-05 14:20
Second Decision	2023-03-20 03:15
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-03-20 09:21
Articles in Press	2023-03-20 09:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-21 06:03
Publish the Manuscript Online	2023-04-20 07:26

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
Manuscript Source	Invited Manuscript
All Author List	Romina Roshanshad, Amirhossein Roshanshad, Reza Fereidooni and Mahnaz Hosseini-Bensenjan
Funding Agency and Grant Number
Corresponding Author	Amirhossein Roshanshad, MD, Postdoctoral Fellow, Research Fellow, Department of MPH, Shiraz University of Medical Sciences, Zand Street, Shiraz 7184731443, Iran. aroshanshad@gmail.com
Key Words	SARS-CoV-2; COVID-19; Liver injury; Chronic liver disease; Management; Liver transplant
Core Tip	Severe acute respiratory syndrome coronavirus-2 can involve the liver and cause damage through different mechanisms. Liver injury can be diagnosed based on alterations in the liver function tests, which can also predict the disease severity and fatality. In patients without underlying liver disease, liver injury is typically mild and can be treated with supportive care. However, it requires additional awareness and appropriate therapy in patients with chronic liver diseases, including autoimmune hepatitis, viral hepatitis, liver cirrhosis, liver transplantation, and nonalcoholic fatty liver disease, which we have discussed in detail.
Publish Date	2023-04-20 07:26
Citation	Roshanshad R, Roshanshad A, Fereidooni R, Hosseini-Bensenjan M. COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations. World J Hepatol 2023; 15(4): 441-459
URL	https://www.wjgnet.com/1948-5182/full/v15/i4/441.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i4.441

Full Article (PDF)	WJH-15-441-with-cover.pdf
Full Article (Word)	WJH-15-441.docx
Manuscript File	80444_Auto_Edited-JLW.docx
Answering Reviewers	80444-Answering reviewers.pdf
Audio Core Tip	80444-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	80444-Conflict-of-interest statement.pdf
Copyright License Agreement	80444-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80444-Language certificate.pdf
Supplementary Material	80444-Supplementary material.pdf
Peer-review Report	80444-Peer-review(s).pdf
Scientific Misconduct Check	80444-CrossCheck.png
Scientific Editor Work List	80444-Scientific editor work list.pdf
CrossCheck Report	80444-CrossCheck report.pdf